Skip to main content
Equibles

Legal & General Group Plc

Position in NUVB — Nuvation Bio Inc.

CIK 764068 London, X0
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,093,029
+$345,833 QoQ
Shares Held
192,435
+10.5% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 242 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. NUVB ranks #109 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in NUVB

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,093,029 192,435
2026-03-31 $747,196 174,172
2025-12-31 $1,728,087 192,867
2025-09-30 $823,715 222,626
2025-06-30 $457,444 234,588
2025-03-31 $393,591 223,632
2024-12-31 $598,038 224,827
2024-09-30 $335,812 146,643
2024-06-30 $378,390 129,586
2024-03-31 $41,514 11,405
2023-12-31 $25,048 16,589
2023-09-30 $119,621 89,270
2023-06-30 $164,815 91,564
2023-03-31 $75,677 45,589
2022-12-31 $78,631 40,954
2022-09-30 $91,736 40,954
2022-06-30 $126,904 39,168
2022-03-31 $229,555 43,642
2021-12-31 $371,322 43,685
2021-09-30 $363,981 36,618
2021-06-30 $92,755 9,963